Lp(a) — The Silent Heart Risk Most People Over 60 Don’t Know They Have

Lp(a) — The Silent Heart Risk Most People Over 60 Don’t Know They Have

Normal cholesterol panel, elevated risk? Possibly—if lipoprotein(a), or Lp(a), wasn’t measured. About 20–30% of people have genetically high Lp(a), which can raise the risk of heart attack, stroke, and aortic valve disease.

“If heart disease runs in your family, test Lp(a) at least once in adulthood.”

Why Lp(a) Matters (and How It Differs from LDL)

Lp(a) is an LDL-like particle with an attached apolipoprotein(a) that makes it stickier and more pro-inflammatory. Elevated levels can accelerate plaque formation and promote clotting. Standard lipid panels often miss it.

Testing tip: Ask for Lp(a) in nmol/L or mg/dL. Levels ≥125 nmol/L (≈ ≥50 mg/dL) are generally considered high.

Action Steps if Lp(a) Is Elevated

  • Lower systemic inflammation: Prioritize fiber-rich, minimally processed foods; manage sleep and stress.
  • Support endothelial function: Focus on nitric-oxide–boosting activity (walking, light intervals, breathwork).
  • Optimize lipids: Address triglycerides, ApoB, and oxidized LDL with diet and movement.
  • Discuss medications: Some lipid-lowering therapies and emerging agents may be considered by your clinician.

Young Again Nutrients That Complement Care

  • Young Again Omega-3 Fish Oil: Supports healthy triglycerides, inflammation balance, and endothelial function.
  • Young Again Curcumin: Anti-inflammatory support for vascular integrity.
  • Young Again CoQ10 Ubiquinol: Mitochondrial energy for cardiac cells; supportive alongside statin therapy.

Note: Lp(a) is largely genetic. Nutrients may not lower Lp(a) itself but can help reduce associated cardiovascular risk. Always coordinate with your healthcare provider.

References

  • Tsimikas, S. (2017). A test in context: Lipoprotein(a). Journal of the American College of Cardiology, 69(6), 692–711.
  • Wilson, D. P., et al. (2019). Lipoprotein(a): Clinician’s guide to assessment and treatment. Journal of Clinical Lipidology, 13(5), 860–872.
  • Enkhmaa, B., et al. (2016). The role of Lp(a) in atherosclerotic cardiovascular disease. Journal of Internal Medicine, 280(2), 100–114.
Back to blog